✦ LIBER ✦

PMH48 VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

✍ Scribed by C Graham; J Mauskopf; AH Lawson; H Ascher-Svanum; D Bruhn; PR Watson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH35 A Cost-Effectiveness Analysis of P

✍ T.R. Einarson; C. Vicente; R. Zilbershtein; C. Piwko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMH35 COST-EFFECTIVENESS OF ORALLY DISSO

✍ H Ascher-Svanum; NM Furiak; RW Klein; LJ Smolen; PR Watson; AH Lawson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH42 COST-EFFECTIVENESS ANALYSIS OF OLA

✍ SM Carroll; N Jemiai; B Suter; P O'Donohoe; U Skjoldborg; J Moller; OK Kleivenes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH21 Cost-Effectiveness of Intramuscula

✍ R.M. Galindo-Suárez; G. Peniche-Otero; J. Herrera-Rojas; G. Baeza-Cruz; A. Nencl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

VALIDATING AN INDUSTRY-SPONSORED MODEL C

✍ Christopher N. Graham; Josephine Mauskopf; Anthony H. Lawson; Haya Ascher-Svanum 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 76 KB

PMH50 COSTS AND EFFECTS OF ILOPERIDONE C

✍ KA Elsaid; M Angelini 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB